Kathryn Maitland1, Peter Olupot-Olupot1, Sarah Kiguli1, George Chagaluka1, Florence Alaroker1, Robert O Opoka1, Ayub Mpoya1, Charles Engoru1, Julius Nteziyaremye1, Macpherson Mallewa1, Neil Kennedy1, Margaret Nakuya1, Cate Namayanja1, Julianna Kayaga1, Sophie Uyoga1, Dorothy Kyeyune Byabazaire1, Bridon M'baya1, Benjamin Wabwire1, Gary Frost1, Imelda Bates1, Jennifer A Evans1, Thomas N Williams1, Pedro Saramago Goncalves1, Elizabeth C George1, Diana M Gibb1, A Sarah Walker1. 1. From the Department of Medicine (K.M., T.N.W.) and Nutrition Research Section (G.F.), Imperial College London, and the Medical Research Council Clinical Trials Unit at University College London (E.C.G., D.M.G., A.S.W.), London, the School of Medicine, Dentistry, and Biomedical Science, Queen's University, Belfast (N.K.), the Liverpool School of Tropical Medicine and Hygiene, Liverpool (I.B.), the Department of Pediatrics, University Hospital of Wales, Cardiff (J.A.E.), and the Centre for Health Economics, University of York, York (P.S.G.) - all in the United Kingdom; Busitema University Faculty of Health Sciences, Mbale Campus, Mbale Regional Referral Hospital (P.O.-O., J.N., C.N.), and the Mbale Blood Transfusion Services (B.W.), Mbale, the Department of Pediatrics, Makerere University and Mulago Hospital (S.K., R.O.O., J.K.), and the Uganda Blood Transfusion Services, National Blood Transfusion Services (D.K.B.), Kampala, and Soroti Regional Referral Hospital, Soroti (F.A., C.E., M.N.) - all in Uganda; the Kenya Medical Research Institute-Wellcome Trust Research Program, Kilifi (K.M., A.M., S.U., T.N.W.); and the College of Medicine and the Malawi-Liverpool-Wellcome Trust Clinical Research Program (G.C., M.M., N.K.) and the Malawi Blood Transfusion Services (B.M.) - all in Blantyre, Malawi.
Abstract
BACKGROUND: Severe anemia (hemoglobin level, <6 g per deciliter) is a leading cause of hospital admission and death in children in sub-Saharan Africa. The World Health Organization recommends transfusion of 20 ml of whole-blood equivalent per kilogram of body weight for anemia, regardless of hemoglobin level. METHODS: In this factorial, open-label trial, we randomly assigned Ugandan and Malawian children 2 months to 12 years of age with a hemoglobin level of less than 6 g per deciliter and severity features (e.g., respiratory distress or reduced consciousness) to receive immediate blood transfusion with 20 ml per kilogram or 30 ml per kilogram. Three other randomized analyses investigated immediate as compared with no immediate transfusion, the administration of postdischarge micronutrients, and postdischarge prophylaxis with trimethoprim-sulfamethoxazole. The primary outcome was 28-day mortality. RESULTS: A total of 3196 eligible children (median age, 37 months; 2050 [64.1%] with malaria) were assigned to receive a transfusion of 30 ml per kilogram (1598 children) or 20 ml per kilogram (1598 children) and were followed for 180 days. A total of 1592 children (99.6%) in the higher-volume group and 1596 (99.9%) in the lower-volume group started transfusion (median, 1.2 hours after randomization). The mean (±SD) volume of total blood transfused per child was 475±385 ml and 353±348 ml, respectively; 197 children (12.3%) and 300 children (18.8%) in the respective groups received additional transfusions. Overall, 55 children (3.4%) in the higher-volume group and 72 (4.5%) in the lower-volume group died before 28 days (hazard ratio, 0.76; 95% confidence interval [CI], 0.54 to 1.08; P = 0.12 by log-rank test). This finding masked significant heterogeneity in 28-day mortality according to the presence or absence of fever (>37.5°C) at screening (P=0.001 after Sidak correction). Among the 1943 children (60.8%) without fever, mortality was lower with a transfusion volume of 30 ml per kilogram than with a volume of 20 ml per kilogram (hazard ratio, 0.43; 95% CI, 0.27 to 0.69). Among the 1253 children (39.2%) with fever, mortality was higher with 30 ml per kilogram than with 20 ml per kilogram (hazard ratio, 1.91; 95% CI, 1.04 to 3.49). There was no evidence of differences between the randomized groups in readmissions, serious adverse events, or hemoglobin recovery at 180 days. CONCLUSIONS: Overall mortality did not differ between the two transfusion strategies. (Funded by the Medical Research Council and Department for International Development, United Kingdom; TRACT Current Controlled Trials number, ISRCTN84086586.).
BACKGROUND: Severe anemia (hemoglobin level, <6 g per deciliter) is a leading cause of hospital admission and death in children in sub-Saharan Africa. The World Health Organization recommends transfusion of 20 ml of whole-blood equivalent per kilogram of body weight for anemia, regardless of hemoglobin level. METHODS: In this factorial, open-label trial, we randomly assigned Ugandan and Malawian children 2 months to 12 years of age with a hemoglobin level of less than 6 g per deciliter and severity features (e.g., respiratory distress or reduced consciousness) to receive immediate blood transfusion with 20 ml per kilogram or 30 ml per kilogram. Three other randomized analyses investigated immediate as compared with no immediate transfusion, the administration of postdischarge micronutrients, and postdischarge prophylaxis with trimethoprim-sulfamethoxazole. The primary outcome was 28-day mortality. RESULTS: A total of 3196 eligible children (median age, 37 months; 2050 [64.1%] with malaria) were assigned to receive a transfusion of 30 ml per kilogram (1598 children) or 20 ml per kilogram (1598 children) and were followed for 180 days. A total of 1592 children (99.6%) in the higher-volume group and 1596 (99.9%) in the lower-volume group started transfusion (median, 1.2 hours after randomization). The mean (±SD) volume of total blood transfused per child was 475±385 ml and 353±348 ml, respectively; 197 children (12.3%) and 300 children (18.8%) in the respective groups received additional transfusions. Overall, 55 children (3.4%) in the higher-volume group and 72 (4.5%) in the lower-volume group died before 28 days (hazard ratio, 0.76; 95% confidence interval [CI], 0.54 to 1.08; P = 0.12 by log-rank test). This finding masked significant heterogeneity in 28-day mortality according to the presence or absence of fever (>37.5°C) at screening (P=0.001 after Sidak correction). Among the 1943 children (60.8%) without fever, mortality was lower with a transfusion volume of 30 ml per kilogram than with a volume of 20 ml per kilogram (hazard ratio, 0.43; 95% CI, 0.27 to 0.69). Among the 1253 children (39.2%) with fever, mortality was higher with 30 ml per kilogram than with 20 ml per kilogram (hazard ratio, 1.91; 95% CI, 1.04 to 3.49). There was no evidence of differences between the randomized groups in readmissions, serious adverse events, or hemoglobin recovery at 180 days. CONCLUSIONS: Overall mortality did not differ between the two transfusion strategies. (Funded by the Medical Research Council and Department for International Development, United Kingdom; TRACT Current Controlled Trials number, ISRCTN84086586.).
Authors: Xin Sun; Matthias Briel; Jason W Busse; John J You; Elie A Akl; Filip Mejza; Malgorzata M Bala; Dirk Bassler; Dominik Mertz; Natalia Diaz-Granados; Per Olav Vandvik; German Malaga; Sadeesh K Srinathan; Philipp Dahm; Bradley C Johnston; Pablo Alonso-Coello; Basil Hassouneh; Stephen D Walter; Diane Heels-Ansdell; Neera Bhatnagar; Douglas G Altman; Gordon H Guyatt Journal: BMJ Date: 2012-03-15
Authors: Kathryn Maitland; Sarah Kiguli; Peter Olupot-Olupot; Charles Engoru; Macpherson Mallewa; Pedro Saramago Goncalves; Robert O Opoka; Ayub Mpoya; Florence Alaroker; Julius Nteziyaremye; George Chagaluka; Neil Kennedy; Eva Nabawanuka; Margaret Nakuya; Cate Namayanja; Sophie Uyoga; Dorothy Kyeyune Byabazaire; Bridon M'baya; Benjamin Wabwire; Gary Frost; Imelda Bates; Jennifer A Evans; Thomas N Williams; Elizabeth C George; Diana M Gibb; A Sarah Walker Journal: N Engl J Med Date: 2019-08-01 Impact factor: 91.245
Authors: Peter Olupot-Olupot; Charles Engoru; Jennifer Thompson; Julius Nteziyaremye; Martin Chebet; Tonny Ssenyondo; Cornelius M Dambisya; Vicent Okuuny; Ronald Wokulira; Denis Amorut; Paul Ongodia; Ayub Mpoya; Thomas N Williams; Sophie Uyoga; Alex Macharia; Diana M Gibb; A Sarah Walker; Kathryn Maitland Journal: BMC Med Date: 2014-04-25 Impact factor: 8.775
Authors: Ayub Mpoya; Sarah Kiguli; Peter Olupot-Olupot; Robert O Opoka; Charles Engoru; Macpherson Mallewa; Yami Chimalizeni; Neil Kennedy; Dorothy Kyeyune; Benjamin Wabwire; Bridon M'baya; Imelda Bates; Britta Urban; Michael Boele von Hensbroek; Robert Heyderman; Margaret J Thomason; Sophie Uyoga; Thomas N Williams; Diana M Gibb; Elizabeth C George; A Sarah Walker; Kathryn Maitland Journal: Trials Date: 2015-12-29 Impact factor: 2.279
Authors: Sophie Uyoga; Ayub Mpoya; Peter Olupot-Olupot; Sarah Kiguli; Robert O Opoka; Charles Engoru; Macpherson Mallewa; Neil Kennedy; Bridon M'baya; Dorothy Kyeyune; Benjamin Wabwire; Imelda Bates; Diana M Gibb; Ann Sarah Walker; Elizabeth C George; Thomas N Williams; Kathryn Maitland Journal: Vox Sang Date: 2019-03-05 Impact factor: 2.144
Authors: Fereydoun Ala; Jean-Pierre Allain; Imelda Bates; Kamel Boukef; Frank Boulton; James Brandful; Elizabeth M Dax; Magdy El Ekiaby; Albert Farrugia; Jed Gorlin; Oliver Hassall; Helen Lee; André Loua; Kathryn Maitland; Dora Mbanya; Zainab Mukhtar; William Murphy; Ohene Opare-Sem; Shirley Owusu-Ofori; Henk Reesink; David Roberts; Oscar Torres; Grace Totoe; Henrik Ullum; Silvano Wendel Journal: PLoS Med Date: 2012-09-11 Impact factor: 11.069
Authors: Sarah Kiguli; Kathryn Maitland; Elizabeth C George; Peter Olupot-Olupot; Robert O Opoka; Charles Engoru; Samuel O Akech; Richard Nyeko; George Mtove; Hugh Reyburn; Michael Levin; Abdel G Babiker; Diana M Gibb; Jane Crawley Journal: BMC Med Date: 2015-02-02 Impact factor: 11.150
Authors: Kathryn Maitland; Sarah Kiguli; Peter Olupot-Olupot; Charles Engoru; Macpherson Mallewa; Pedro Saramago Goncalves; Robert O Opoka; Ayub Mpoya; Florence Alaroker; Julius Nteziyaremye; George Chagaluka; Neil Kennedy; Eva Nabawanuka; Margaret Nakuya; Cate Namayanja; Sophie Uyoga; Dorothy Kyeyune Byabazaire; Bridon M'baya; Benjamin Wabwire; Gary Frost; Imelda Bates; Jennifer A Evans; Thomas N Williams; Elizabeth C George; Diana M Gibb; A Sarah Walker Journal: N Engl J Med Date: 2019-08-01 Impact factor: 91.245
Authors: Jeffrey L Carson; Simon J Stanworth; Jane A Dennis; Marialena Trivella; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Dorée; Paul C Hébert Journal: Cochrane Database Syst Rev Date: 2021-12-21
Authors: Titus K Kwambai; Aggrey Dhabangi; Richard Idro; Robert Opoka; Victoria Watson; Simon Kariuki; Nickline A Kuya; Eric D Onyango; Kephas Otieno; Aaron M Samuels; Meghna R Desai; Michael Boele van Hensbroek; Duolao Wang; Chandy C John; Bjarne Robberstad; Kamija S Phiri; Feiko O Ter Kuile Journal: N Engl J Med Date: 2020-12-03 Impact factor: 176.079
Authors: Hans Ackerman; Aintzane Ayestaran; Christopher H O Olola; Muminatou Jallow; Tsiri Agbenyega; Kalifa Bojang; David J Roberts; Sanjeev Krishna; Peter G Kremsner; Charles R Newton; Terrie Taylor; Clarissa Valim; Climent Casals-Pascual Journal: Lancet Haematol Date: 2020-11 Impact factor: 18.959
Authors: Katrin Scheu; Ayola Akim Adegnika; Marylyn M Addo; Daniel Ansong; Jakob P Cramer; Svenja Fürst; Peter G Kremsner; Florian Kurth; Thomas Jacobs; Jürgen May; Michael Ramharter; Justice Sylverken; Christof D Vinnemeier; Tsiri Agbenyega; Thierry Rolling Journal: Sci Rep Date: 2019-12-02 Impact factor: 4.379
Authors: Peter Olupot-Olupot; Florence Aloroker; Ayub Mpoya; Hellen Mnjalla; George Passi; Margaret Nakuya; Kirsty Houston; Nchafatso Obonyo; Mainga Hamaluba; Jennifer A Evans; Roisin Connon; Elizabeth C George; Diana M Gibb; Kathryn Maitland Journal: Wellcome Open Res Date: 2021-06-23